Shmerling D H, Franckx J
J Pediatr Gastroenterol Nutr. 1986 Jul-Aug;5(4):565-9.
The diagnosis of celiac disease (CD) was uniformly established between 1960 and 1983 in 314 infants and children according to the following criteria: a flat proximal small bowel mucosa in untreated patients and an unequivocal response and remission on a gluten-free diet (GFD). In 91 patients, one or more interruptions of the GFD (challenges) were documented by repeated intestinal biopsies. Sixty-eight percent of the challenges were initiated by the patients themselves. Seventy-one patients (Group A, 81.4%) had a flat mucosa after 0.25-14.67 years off diet. In 11 (Group B, 12%), a successive deterioration of the mucosa occurred during 0.5-6.67 years after interruption of GFD without becoming flat. Six patients (Group C, 6.6%) had a normal intestinal mucosa after 2.24-6.92 years off diet. Three patients are still under study, being off diet for less than 2 years. Median age at diagnosis was similar in all three groups (1.16, 1.16, and 1.12 years). Median duration of GFD prior to challenge was 4.54 years in Group A, 12.16 years in Group B (p less than 0.001), and 6.38 years in Group C. A mucosal relapse within 2 years after the beginning of challenge was observed in 21 of 24 patients (87.5%) studied longitudinally during planned challenges. It is concluded that only a minority (6.6%) of CD patients, when diagnosed as above, will not relapse after an interruption of GFD and that another small group (12%) will deteriorate very slowly. Routine gluten challenges in all CD patients, interrupting established life and dietary habits and including repeated biopsies in the majority of patients who deteriorate and relapse, seem therefore not justifiable.
1960年至1983年间,依据以下标准,在314名婴幼儿和儿童中明确诊断出乳糜泻(CD):未经治疗的患者近端小肠黏膜扁平,且在无麸质饮食(GFD)情况下有明确的反应和缓解。91名患者中,通过重复肠道活检记录到一次或多次中断GFD(激发试验)。68%的激发试验由患者自身发起。71名患者(A组,81.4%)在停止饮食0.25 - 14.67年后黏膜扁平。11名患者(B组,12%)在中断GFD后0.5 - 6.67年期间黏膜逐渐恶化但未变扁平。6名患者(C组,6.6%)在停止饮食2.24 - 6.92年后肠道黏膜正常。3名患者仍在研究中,停止饮食时间不足2年。三组患者的诊断中位年龄相似(分别为1.16岁、1.16岁和1.12岁)。激发试验前GFD的中位持续时间在A组为4.54年,B组为12.16年(p < 0.001),C组为6.38年。在计划的激发试验期间纵向研究的24名患者中,21名(87.5%)在激发试验开始后2年内出现黏膜复发。结论是,以上述方式诊断的CD患者中,只有少数(6.6%)在中断GFD后不会复发,另有一小部分(12%)会非常缓慢地恶化。因此,对所有CD患者进行常规麸质激发试验,中断既定的生活和饮食习惯,且大多数恶化和复发的患者都要进行重复活检,似乎并不合理。